Table 5 |
||||
| Results of Cytokeratin 7 & 20, villin and CDX-2 immunostaining of primary bladder adenocarcinoma, metastatic and primary colorectal adenocarcinoma and urothelial carcinoma | ||||
| PBA | MCA | CA | UC | |
| Cytokeratin 7 | 4 (33.3%) | 1 (8.3%) | 0 | 5 (100%) |
| Cytokeratin 20 | 12 (100%) | 12 (100%) | 5 (100%) | 2 (40%) |
| Villin | 12 (100%) | 11 (91.7%) | 5 (100%) | 0 |
| CDX-2 | 10 (83.3%) | 12 (100%) | 5 (100%) | 0 |
CA Colorectal adenocarcinoma, CM cytoplasmic staining with membranous accentuation, MCA metastatic colorectal adenocarcinoma, UC urothelial carcinoma.
Roy et al. Diagnostic Pathology 2012 7:151 doi:10.1186/1746-1596-7-151
